Phase I Study of Selinexor in Combination with Salvage Chemotherapy in Adults with Relapsed or Refractory Acute Myeloid Leukemia

Investigators conducted a phase I, dose-escalation study of selinexor with mitoxantrone, etoposide, and cytarabine in 23 patients aged < 60 years with relapsed or refractory AML.